UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Molecular cancer, 2022-01, Vol.21 (1), p.21-21, Article 21

2022

Volltextzugriff (PDF)

Metformin Inhibits Castration-induced EMT in Prostate Cancer by Repressing COX2/PGE2/STAT3 Axis

Cancer letters, 2017-03, Vol.389, p.23-32

2017

Volltextzugriff (PDF)

Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Pharmacological research, 2019-06, Vol.144, p.79-89

2019

Volltextzugriff (PDF)

Twist: a molecular target in cancer therapeutics

Tumor biology, 2013-10, Vol.34 (5), p.2497-2506

2013

Volltextzugriff (PDF)

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Clinical cancer research, 2018-11, Vol.24 (22), p.5622-5634

2018

Volltextzugriff (PDF)

Editorial: Regulation and dysfunction of CSK and CHK

Frontiers in cell and developmental biology, 2023-07, Vol.11, p.1254961-1254961

2023

Volltextzugriff (PDF)

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

Nature, 2006-07, Vol.442 (7100), p.312-316

2006

Volltextzugriff (PDF)

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Oncogene, 2021-03, Vol.40 (11), p.1974-1987

2021

Volltextzugriff (PDF)

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT

Cell death & disease, 2017-08, Vol.8 (8), p.e3007-e3007

2017

Volltextzugriff (PDF)

Targeted therapies for advanced non-small cell lung cancer

Oncotarget, 2018-12, Vol.9 (101), p.37589-37607

2018

Volltextzugriff (PDF)

Regulation, targets and functions of CSK

Frontiers in cell and developmental biology, 2023-06, Vol.11, p.1206539-1206539

2023

Volltextzugriff (PDF)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma

Frontiers in endocrinology (Lausanne), 2020-11, Vol.11, p.586857-586857

2020

Volltextzugriff (PDF)

Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor

The Prostate, 2015-08, Vol.75 (11), p.1187-1196

2015

Volltextzugriff (PDF)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT

Frontiers in oncology, 2020-07, Vol.10, p.1234-1234

2020

Volltextzugriff (PDF)

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway

Immunology letters, 2016-04, Vol.172, p.1-10

2016

Volltextzugriff (PDF)

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Oncogene, 2021-08, Vol.40 (34), p.5356-5356

2021

Volltextzugriff (PDF)

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Oncotarget, 2016-05, Vol.7 (19), p.28235-28246

2016

Volltextzugriff (PDF)

Germline Mutations in Patients With Early-Onset Prostate Cancer

Frontiers in oncology, 2022-06, Vol.12, p.826778-826778

2022

Volltextzugriff (PDF)

Regulation, targets and functions of CHK

Frontiers in cell and developmental biology, 2022-12, Vol.10, p.1068952-1068952

2022

Volltextzugriff (PDF)

Incidence of lung cancer among healthcare workers in Hunan Province and analysis of related risk factors

Frontiers in public health, 2023, Vol.11, p.1280316-1280316

2023

Volltextzugriff (PDF)

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Frontiers in pharmacology, 2022-04, Vol.13, p.838171-838171

2022

Volltextzugriff (PDF)

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency

Frontiers in endocrinology (Lausanne), 2023-03, Vol.14, p.1095719-1095719

2023

Volltextzugriff (PDF)

The Many Faces of MTA3 Protein in Normal Development and Cancers

Current protein & peptide science, 2016-01, Vol.17 (8), p.726-734

2016

Volltextzugriff (PDF)

Key molecular DNA damage responses of human cells to radiation

Frontiers in cell and developmental biology, 2024-07, Vol.12, p.1422520

2024

Volltextzugriff (PDF)

Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations

BMC endocrine disorders, 2023-04, Vol.23 (1), p.77-77, Article 77

2023

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEndocrine Connections

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(113)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(72)
Humans
(49)
Oncology
(33)
Animals
(26)
Male
(23)
Cell Line, Tumor
(19)
Cell Biology
(18)
Female
(18)
Prostate Cancer
(15)
Mice
(13)
Prognosis
(12)
Gene Expression Regulation, Neoplastic
(11)
Apoptosis
(10)
Biochemistry & Molecular Biology
(10)
Signal Transduction
(10)
Cancer
(9)
Metastasis
(9)
Middle Aged
(9)
Esophageal Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Metformin Inhibits Castration-induced EMT in Prostate Cancer by Repressing COX2/PGE2/STAT3 Axis

Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Twist: a molecular target in cancer therapeutics

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Editorial: Regulation and dysfunction of CSK and CHK

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT

Targeted therapies for advanced non-small cell lung cancer

Regulation, targets and functions of CSK

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma

Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Germline Mutations in Patients With Early-Onset Prostate Cancer

Regulation, targets and functions of CHK

Incidence of lung cancer among healthcare workers in Hunan Province and analysis of related risk factors

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency

The Many Faces of MTA3 Protein in Normal Development and Cancers

Key molecular DNA damage responses of human cells to radiation

Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations

Aktive Filter

Suchergebnisse filtern